301584SZSE

Verification Opinion of CITIC Securities Co., Ltd. on Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. Using Part of Idle Raised Funds and Idle Own Funds for Cash Management

✨ AI Summary

CITIC Securities, as the sponsor for Shanghai Jianfa Zhixin Medical Technology Group's IPO, has verified the company's plan to use up to 1 billion RMB of idle raised funds and 200 million RMB of idle own funds for cash management. This decision aims to enhance fund efficiency without affecting ongoing projects or operations. The cash management period is set for up to 12 months, with strict risk controls in place.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

CITIC Securities Co., Ltd. (hereinafter referred to as "CITIC Securities" or "the Sponsor") is the sponsor for the initial public offering (IPO) and ongoing supervision of Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. (hereinafter referred to as "Jianfa Zhixin" or "the Company"). In accordance with relevant regulations, including the "Administrative Measures for the Sponsorship of Securities Issuance and Listing," the "Shenzhen Stock Exchange GEM Listing Rules," and the "Self-Regulatory Guidelines No. 2 for Listed Companies on the Shenzhen Stock Exchange - Standardized Operations of GEM Listed Companies," CITIC Securities has conducted a verification of Jianfa Zhixin's use of part of its idle raised funds and idle own funds for cash management. The specific situation is as follows:

I. Basic Situation of Raised Funds

According to the China Securities Regulatory Commission's approval (Zheng Jian Xu Ke [2025] No. 1337) and with the consent of the Shenzhen Stock Exchange, the Company issued 63,193,277 shares of RMB ordinary shares (A shares) at an issuance price of RMB 7.05 per share, raising a total of RMB 445.5126 million. After deducting issuance costs of RMB 82.1781 million (excluding tax), the actual net raised funds amounted to RMB 363.3345 million. The raised funds were transferred to the Company's designated account on September 22, 2025, and Yongcheng Accounting Firm (Special General Partnership) verified the arrival of the raised funds, issuing a "Verification Report" (Yongcheng Yan Zi [2025] No. 361Z0047). The Company has stored the raised funds in a special account and signed a "Tripartite/Four-party Supervision Agreement" with the bank where the special account is held and the sponsor to implement special account management.

II. Investment Projects and Usage of Raised Funds

According to the "Prospectus for the Initial Public Offering of Shares and Listing on the GEM of Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd." and the announcement regarding the adjustment of the amount of raised funds to be invested in projects, the raised funds are intended for the following projects:

No.Project NameProject Investment AmountOriginal Planned Investment AmountAdjusted Investment Amount
1Information System Upgrade Project140,159,500140,159,500105,000,000
2Medical Consumables Intensive Operation Service Project104,077,600104,077,60078,000,000
3Supplementing Working Capital240,000,000240,000,000180,334,500
Total484,237,100484,237,100363,334,500

Currently, the Company is orderly advancing the construction of investment projects using the raised funds. Due to the construction of some projects requiring a certain period, there is a temporary idle situation with part of the raised funds. Without affecting the construction of investment projects and the normal operation of the Company, the Company intends to reasonably utilize the idle raised funds for cash management to improve the efficiency of fund usage.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.